Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Lowered to $9 at Goldman Sachs

March 3, 2025 6:29 AM
Goldman Sachs analyst Salveen Richter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles